Acrongenomics, Inc. (OTCBB: AGNM) is a publicly traded company that focuses on investing and commercializing novel technology platforms concerning the Life Sciences sector. Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, customer-orientated applications.
Contact Info:
www.acrongen.com
info@acrongen.com
Phone: +41 22 71 65 300
Fax: +41 22 71 65 319
Street: 14, Rue Kleberg
City: Geneva
Country: Switzerland
Postal Code: CH-1201